The countdown has begun in Turkey’s national pharmaceutical project, which pays 30 billion lira annually for the patent of drugs. With the Turkish Health Investments Fund, which is planned to be established quickly, investments will be made for the studies of Turkish scientists living in the USA.

Drawing attention with its “nationalization” moves in strategic areas, Turkey aims to reduce the annual bill of 30 billion liras paid abroad for the patents of drugs with its national pharmaceutical project. With the Turkish Health Investments Fund, which is planned to be established quickly, the national drug studies of Turkish scientists living in the USA, patented by Turkey, will be financed.